FAQ

Coartem

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
051020012017

Related topics

Related topics

3 relations

Broader (3)

artemetherartemether-lumefantrine combinationlumefantrine

Related mentions per year

Related mentions per year

1982-2018
19801990200020102020
Coartem
lumefantrine
artemether
artemether-lumefantrine combination

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory…
OBJECTIVE To compare, in a phase IV trial, the efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) dosed at 300… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum.
Background. Artemisinin-based combination therapy (ACT) reduces microscopically confirmed gametocytemia and mosquito infection… (More)
Is this relevant?
2006
2006
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.
In April 2004, 137 children 6-59 months of age with uncomplicated Plasmodium falciparum (Pf) malaria (Caala, Central Angola) were… (More)
  • figure 1
  • table 1
Is this relevant?
2006
2006
[Coartem and fansimef in the treatment of falciparum malaria].
From 2001 to 2003, anti-malarial combination coartem and fansimef, recommended by WHO, were used to treat falciparum malaria in… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
Artemisinin derivative-based combination therapy is expected to suppress the development of Plasmodium falciparum drug resistance… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.
Approximately one million children die from malaria each year. A recently approved artemisinin-based tablet, Coartem (co… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Reduction of Malaria Transmission to Anopheles Mosquitoes with a Six-Dose Regimen of Co-Artemether
BACKGROUND Resistance of malaria parasites to chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) is increasing in prevalence in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
Measuring baseline levels of adherence and identifying risk factors for non-adherence are important steps before the introduction… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2003
2003
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum…
An open randomized comparison of two-fixed dose artemisinin derivative-containing combination regimens was conducted in adults… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
The efficacy-safety and pharmacokinetics of the six-dose regimen of artemether-lumefantrine (Coartem/Riamet; Novartis Pharma AG… (More)
Is this relevant?